Over-expression of catalytically inactive PLD2 inhibited migration of ECs [15], fibroblasts [61] and cancer cells [16], [62] suggesting a role for PLD2/PA signaling in regulation of cell motility. The gene discussed is PLD2; the disease is cancer.